Novartis Ag v. Msn Laboratories Pvt. Ltd.
Case brief
What is this about?
Novartis AG v. MSN Laboratories Pvt Ltd; CS(COMM) 370/2021; Delhi High Court; Saurabh Banerjee, J.; consent decree; Order XXIII Rule 3 CPC; settlement of patent infringement suit; Pazopanib; suit patent IN’284; plaintiff foregoes damages and accounts of profits; defendant foregoes counterclaims; full and final settlement; refund of 75% court fees; Section 16 Court Fees Act 1870; I.A. 9084/2025; pending applications I.A. 12667/2023 and I.A. 21222/2023 not pressed; suit disposed of 07.04.2025.
What did the court decide?
Consent decree: suit decreed in terms of the settlement in para 4 of I.A. 9084/2025 — plaintiff foregoes damages, rendition of accounts of profits, delivery-up and other claims (prayer paragraphs 28(b) to (f) of the Plaint); defendant foregoes claims in prayer paragraphs 24(a) to (d) of the Written Statement; no party entitled to any claims or damages; refund of 75% of court fees paid by plaintiff via certificate to be issued by the Registry.